Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

In the last 30 years, HIV rates have gone down, in large part because of the game-changing prescription drug pre-exposure ...

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

Learn about the changing trend in pre exposure prophylaxis medication prescription for HIV patients in the US over the past ...

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...

Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) product ... women – those who identify with the gender they were born with – contracted HIV while on the drug. Hasina Subedar, senior ...

(HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and ... Generic TDF/FTC reached the highest monthly share of users among all medications from December 2021 to December ...